PTK2 and lung carcinoma: Inhibition of IGSF10 expression by IGSF10-small interfering RNA was demonstrated to inhibit cancer cell proliferation, enhance adhesion between cells and matrix, and increase the survival rate of patients with lung cancer by activating the integrin-β1/FAK pathway42.